SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-014207
Filing Date
2019-11-14
Accepted
2019-11-14 16:05:08
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q20190930.htm 10-Q 1924308
2 EXHIBIT 31.1 q32019cercex-311.htm EX-31.1 15871
3 EXHIBIT 32.1 q32019cercex-321.htm EX-32.1 10149
10 pipeline10q32019.jpg GRAPHIC 185571
11 rdmilestone10q32019.jpg GRAPHIC 169555
  Complete submission text file 0001628280-19-014207.txt   10043993

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cerc-20190930.xml EX-101.INS 1863541
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20190930.xsd EX-101.SCH 69666
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20190930_cal.xml EX-101.CAL 96645
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20190930_def.xml EX-101.DEF 464844
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20190930_lab.xml EX-101.LAB 928498
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20190930_pre.xml EX-101.PRE 588814
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 191219980
SIC: 2834 Pharmaceutical Preparations